# Relacorilant Food Effect Study in Healthy Subjects

> **NCT03442621** · PHASE1 · COMPLETED · sponsor: **Corcept Therapeutics** · enrollment: 30 (actual)

## Conditions studied

- Healthy
- Food-drug Interaction

## Interventions

- **DRUG:** Relacorilant Fasted
- **DRUG:** Relacorilant with a high fat breakfast
- **DRUG:** Relacorilant with a moderate breakfast

## Key facts

- **NCT ID:** NCT03442621
- **Lead sponsor:** Corcept Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-01-16
- **Primary completion:** 2018-02-28
- **Final completion:** 2018-03-09
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2018-05-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03442621

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03442621, "Relacorilant Food Effect Study in Healthy Subjects". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03442621. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*